Drozd, Daniel R.Saag, Michael S.Westfall, Andrew O.Mathews, William ChrisHaubrich, RichardBoswell, Stephen L.Cole, Stephen R.Porter, DonnaKitahata, Mari M.Juday, TimothyRosenblatt, Lisa2017-06-152017Drozd, D. R., M. S. Saag, A. O. Westfall, W. C. Mathews, R. Haubrich, S. L. Boswell, S. R. Cole, et al. 2017. “Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.” Medicine 96 (14): e6275. doi:10.1097/MD.0000000000006275. http://dx.doi.org/10.1097/MD.0000000000006275.http://nrs.harvard.edu/urn-3:HUL.InstRepos:33029882Abstract We determined risk of virologic failure (VF) in individuals initiating tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR). We found no significant difference in the risk of VF, though did observe a trend toward more VF and M184 V mutations among persons initiating MTR. Temporal trends in care may have confounded results.en-USObservational StudyARTatriplacomparative effectivenessHIVsingle tablet regimenJournal Article2017-06-1510.1097/MD.0000000000006275